According to Inovio Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -17,085.40%. At the end of 2021 the company had an Operating Margin of -17,085.39%.
Year | Operating Margin | Change |
---|---|---|
2021 | -17,085.39% | 677.35% |
2020 | -2,197.89% | -25.19% |
2019 | -2,938.01% | 844.71% |
2018 | -311.00% | 48.86% |
2017 | -208.92% | 0.2% |
2016 | -208.49% | 171.12% |
2015 | -76.90% | -77.75% |
2014 | -345.61% | -29.57% |
2013 | -490.69% | 2.52% |
2012 | -478.63% | 110.94% |
2011 | -226.90% | -27.46% |
2010 | -312.79% | 104.38% |
2009 | -153.04% | -76.5% |
2008 | -651.14% | 96.91% |
2007 | -330.68% | -14.07% |
2006 | -384.82% | 72.81% |
2005 | -222.69% | -77.42% |
2004 | -986.27% | -88.03% |
2003 | -8,237.11% | 164.23% |
2002 | -3,117.36% | 1804.82% |
2001 | -163.66% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 22.88% | -100.13% | ๐บ๐ธ USA |
Novartis NVS | 17.27% | -100.10% | ๐จ๐ญ Switzerland |
Pfizer PFE | 34.61% | -100.20% | ๐บ๐ธ USA |
Gilead Sciences GILD | 26.84% | -100.16% | ๐บ๐ธ USA |
Merck MRK | 27.73% | -100.16% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | 22.54% | -100.13% | ๐ฌ๐ง UK |
Cleveland BioLabs
CBLI | N/A | N/A | ๐บ๐ธ USA |
Arrowhead Pharmaceuticals
ARWR | -71.00% | -99.58% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.